Guc I, Yalcin E, Cavusoglu K, Acar A
Sci Rep. 2022; 12(1):14471.
PMID: 36008536
PMC: 9411558.
DOI: 10.1038/s41598-022-18791-8.
Seven B, Kultigin , Cavusoglu , Yalcin E, Acar A
Sci Rep. 2022; 12(1):11439.
PMID: 35794216
PMC: 9259609.
DOI: 10.1038/s41598-022-15800-8.
Kasyanenko N, Qiushi Z, Bakulev V, Sokolov P, Yakovlev K
Polymers (Basel). 2022; 14(10).
PMID: 35631926
PMC: 9143540.
DOI: 10.3390/polym14102044.
Haririan I, Alavidjeh M, Khorramizadeh M, Shafiee Ardestani M, Ghane Z, Namazi H
Int J Nanomedicine. 2010; 5:63-75.
PMID: 20161988
PMC: 2819903.
DOI: 10.2147/ijn.s8595.
Hagerlof M, Papsai P, Chow C, Elmroth S
J Biol Inorg Chem. 2006; 11(8):974-90.
PMID: 16953416
DOI: 10.1007/s00775-006-0157-y.
Influence of cisplatin intrastrand crosslinking on the conformation, thermal stability, and energetics of a 20-mer DNA duplex.
Poklar N, Pilch D, Lippard S, Redding E, Dunham S, Breslauer K
Proc Natl Acad Sci U S A. 1996; 93(15):7606-11.
PMID: 8755522
PMC: 38793.
DOI: 10.1073/pnas.93.15.7606.
Separation of platinated derivatives of nucleic acid bases on Sephadex G10.
Olinski R, Walter Z
Mol Biol Rep. 1983; 9(3):197-201.
PMID: 6685225
DOI: 10.1007/BF00775368.
The primary mode of binding of cisplatin to a B-DNA dodecamer: C-G-C-G-A-A-T-T-C-G-C-G.
Wing R, Pjura P, Drew H, DICKERSON R
EMBO J. 1984; 3(5):1201-6.
PMID: 6539674
PMC: 557495.
DOI: 10.1002/j.1460-2075.1984.tb01951.x.
Filamentous growth of Escherichia coli K12 elicited by dimeric, mixed-valence complexes of ruthenium.
Gibson J, Poole R, Hughes M, Rees J
Arch Microbiol. 1984; 139(2-3):265-71.
PMID: 6393892
DOI: 10.1007/BF00402012.
Antitumor activity of platinum complexes.
Drobnik J
Cancer Chemother Pharmacol. 1983; 10(3):145-9.
PMID: 6345016
DOI: 10.1007/BF00255749.
Effect of cis-platinum(II)diamminodichloride on wild type and deoxyribonucleic acid repair deficient mutants of Escherichia coli.
Beck D, Brubaker R
J Bacteriol. 1973; 116(3):1247-52.
PMID: 4584807
PMC: 246480.
DOI: 10.1128/jb.116.3.1247-1252.1973.
The chemical and biological effects of cis-dichlorodiammineplatinum (II), an antitumor agent, on DNA.
Munchausen L
Proc Natl Acad Sci U S A. 1974; 71(11):4519-22.
PMID: 4548188
PMC: 433918.
DOI: 10.1073/pnas.71.11.4519.
Platinum coordination complexes in cancer chemotherapy.
Rosenberg B
Naturwissenschaften. 1973; 60(9):399-406.
PMID: 4203933
DOI: 10.1007/BF00623551.
Protection of antiproliferative effect of cis-diamminedichloroplatinum (II) by sodium thiosulfate.
Abe R, Akiyoshi T, Tsuji H, Baba T
Cancer Chemother Pharmacol. 1986; 18(2):98-100.
PMID: 3791566
DOI: 10.1007/BF00262275.
Interaction of cis-diamminedichloroplatinum(II) with phi X174 DNA.
Zahoor A, Lafleur M, Edwards D
Br J Cancer. 1986; 53(6):829-33.
PMID: 2941047
PMC: 2001415.
DOI: 10.1038/bjc.1986.140.
Effect of cis-platinum(II)diamminodichloride on cell division of Hyphomicrobium and Caulobacter.
Moore R, Brubaker R
J Bacteriol. 1976; 125(1):317-23.
PMID: 1245459
PMC: 233365.
DOI: 10.1128/jb.125.1.317-323.1976.
Effect of platinum and palladium salts on thymidine incorporation into DNA of rat tissues.
Fisher R, HOLBROOK Jr D, Leake H, Brubaker P
Environ Health Perspect. 1975; 12:57-62.
PMID: 1227861
PMC: 1475016.
DOI: 10.1289/ehp.751257.
Studies on cis-dichlorodiammineplatinum (II) as a radiosensitizer.
Alvarez M, Cobreros G, Heras A, Lopez Zumel M
Br J Cancer Suppl. 1978; 3:68-72.
PMID: 277260
PMC: 2149413.
Effect of radiation on cis-dichlorodiammineplatinum (II) and DNA in aqueous solution.
Richmond R, Simic M
Br J Cancer Suppl. 1978; 3:20-3.
PMID: 277227
PMC: 2149397.
Antineoplastic drugs: clinical pharmacology and therapeutic use.
Bender R, Zwelling L, Doroshow J, Locker G, Hande K, Murinson D
Drugs. 1978; 16(1):46-87.
PMID: 78795
DOI: 10.2165/00003495-197816010-00003.
